ProfileGDS4718 / 235509_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 81% 79% 82% 84% 87% 88% 83% 84% 86% 84% 85% 87% 89% 88% 81% 84% 91% 83% 69% 81% 85% 86% 83% 80% 91% 83% 82% 80% 84% 76% 81% 82% 83% 86% 80% 88% 82% 83% 81% 86% 84% 74% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2858883
GSM549102patient 115, normal, homogenized [OPG study]7.864881
GSM549104patient 119, normal, homogenized [OPG study]7.8074979
GSM549108patient 138, normal, homogenized [OPG study]7.9807482
GSM549119patient 077, normal, homogenized [OPG study]8.2635284
GSM549133patient 032, cancer, homogenized [OPG study]8.8853687
GSM549139patient 042, cancer, homogenized [OPG study]8.8764888
GSM549099patient 107, normal, homogenized [OPG study]8.1354283
GSM549109patient 139, normal, homogenized [OPG study]8.2527184
GSM549110patient 046, normal, homogenized [OPG study]8.5607986
GSM549114patient 063, normal, homogenized [OPG study]8.482984
GSM549122patient 082, normal, homogenized [OPG study]8.4404885
GSM549134patient 033, cancer, homogenized [OPG study]8.7714387
GSM549136patient 036, cancer, homogenized [OPG study]9.1646489
GSM549140patient 044, cancer, homogenized [OPG study]8.9796288
GSM549111patient 047, normal, homogenized [OPG study]7.9974381
GSM549113patient 057, normal, homogenized [OPG study]8.4601484
GSM549132patient 031, cancer, homogenized [OPG study]9.2661591
GSM549137patient 038, cancer, homogenized [OPG study]8.2737683
GSM549142patient 047, cancer, homogenized [OPG study]6.7775969
GSM549100patient 110, normal, homogenized [OPG study]7.8797481
GSM549107patient 135, normal, homogenized [OPG study]8.4432685
GSM549115patient 068, normal, homogenized [OPG study]8.7780586
GSM549116patient 072, normal, homogenized [OPG study]8.2621183
GSM549120patient 078, normal, homogenized [OPG study]7.8098380
GSM549131patient 030, cancer, homogenized [OPG study]9.4164491
GSM549118patient 074, normal, homogenized [OPG study]8.2815783
GSM549129patient 027, cancer, homogenized [OPG study]8.0778382
GSM549123patient 088, normal, homogenized [OPG study]7.8473580
GSM549124patient 006, cancer, homogenized [OPG study]8.189684
GSM549126patient 015, cancer, homogenized [OPG study]7.4004476
GSM549128patient 025, cancer, homogenized [OPG study]8.0887281
GSM549103patient 117, normal, homogenized [OPG study]7.9455782
GSM549117patient 073, normal, homogenized [OPG study]8.3496383
GSM549138patient 041, cancer, homogenized [OPG study]8.5730386
GSM549141patient 045, cancer, homogenized [OPG study]8.0254580
GSM549130patient 028, cancer, homogenized [OPG study]8.7287388
GSM549101patient 111, normal, homogenized [OPG study]8.0013382
GSM549105patient 128, normal, homogenized [OPG study]8.1583683
GSM549106patient 134, normal, homogenized [OPG study]8.0919681
GSM549112patient 048, normal, homogenized [OPG study]8.6093186
GSM549125patient 011, cancer, homogenized [OPG study]8.3189984
GSM549127patient 024, cancer, homogenized [OPG study]7.3350874
GSM549135patient 035, cancer, homogenized [OPG study]8.9409388